These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 22627631

  • 1. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
    Cakir A, Gönül II, Uluoğlu O.
    Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A, Sussman ZM, Lawson D, Cohen C.
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [Abstract] [Full Text] [Related]

  • 6. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L, Silveira Graudenz M, Zelmanowicz A, Cancela A, Werutsky G, Rovere RK, Garicochea B.
    Tumori; 2010 Sep; 96(6):966-70. PubMed ID: 21388060
    [Abstract] [Full Text] [Related]

  • 7. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.
    Anticancer Res; 2003 Feb; 23(1B):669-73. PubMed ID: 12680165
    [Abstract] [Full Text] [Related]

  • 10. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
    Barnes PJ, Boutilier R, Chiasson D, Rayson D.
    Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.
    Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, Narod SA, Hanna WM.
    Breast Cancer Res Treat; 2009 Nov; 118(1):131-7. PubMed ID: 19189211
    [Abstract] [Full Text] [Related]

  • 19. [Metaplastic carcinomas of the breast: a morphological and immunohistochemical study].
    Gauchotte G, Gauchotte E, Bressenot A, Verhaeghe JL, Guillemin F, Leroux A, Genin P.
    Ann Pathol; 2011 Feb; 31(1):18-27. PubMed ID: 21349384
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.